Xenon Pharmaceuticals’ (XENE) “Outperform” Rating Reiterated at William Blair
William Blair restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report ...
William Blair Reaffirms “Outperform” Rating for Vital Farms (NASDAQ:VITL)
William Blair reiterated their outperform rating on shares of Vital Farms (NASDAQ:VITL – Free Report) in a report published on Friday morning,RTT News reports. William Blair also issued estimates for ...
Colliers International Group’s (CIGI) “Outperform” Rating Reaffirmed at William Blair
William Blair restated their outperform rating on shares of Colliers International Group (NASDAQ:CIGI – Free Report) (TSE:CIGI) in a report published on Friday morning,RTT News reports. Other equities ...
Alignment Healthcare’s (ALHC) “Outperform” Rating Reiterated at William Blair
William Blair restated their outperform rating on shares of Alignment Healthcare (NASDAQ:ALHC – Free Report) in a research report released on Friday,RTT News reports. Several other equities research ...
William Blair Predicts First Solar Q1 Earnings
Analysts at William Blair issued their Q1 2025 earnings per share estimates for First Solar in a note issued to investors on ...
Q3 Earnings Forecast for Salesforce Issued By William Blair
Investment analysts at William Blair boosted their Q3 2026 earnings per share (EPS) estimates for shares of Salesforce in a ...
Kezar Life Sciences (NASDAQ:KZR) Given “Outperform” Rating at William Blair
William Blair restated their outperform rating on shares of Kezar Life Sciences (NASDAQ:KZR – Free Report) in a research report released on Friday, Marketbeat Ratings reports. Several other research ...
What is William Blair’s Forecast for VERV Q1 Earnings?
William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, ...
William Blair Initiates Coverage on Structure Therapeutics (NASDAQ:GPCR)
William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an outperform ...
Q1 Earnings Forecast for CGEM Issued By William Blair
William Blair issued their Q1 2026 EPS estimates for Cullinan Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Phipps expects that the company will post earnings of ...
Hosted on MSN2d
William Blair Initiates Coverage of Altimmune (ALT) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...
What is William Blair’s Forecast for MDxHealth Q1 Earnings?
Analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of MDxHealth in a research ...